Semaglutide
medicationA GLP-1 medication that reduces appetite, approved for weight management and type 2 diabetes.
Guide
“FDA approved” means FDA reviewed a drug, biologic or high-risk device for safety and effectiveness before sale. “FDA cleared” means a moderate-risk device was shown substantially equivalent to one already sold. Compounded drugs, supplements and cosmetics are not FDA-approved, and “FDA registered” means only that a facility or product is listed with FDA.

It means FDA reviewed the product before it could be sold. New drugs and biological products must be FDA-approved before they are marketed, and the highest-risk medical devices, Class III, need a premarket approval application. FDA

Approved drugs are listed in Drugs@FDA, and their official prescribing information is published on DailyMed. Drugs@FDA
“Cleared” is FDA’s word for a device that passed a 510(k) review: the maker showed it is substantially equivalent to a device already legally on the market. FDA’s order “clears” it for sale. It is a different and generally lighter review than premarket approval. FDA

Substantial equivalence means the device has the same intended use and technological characteristics as a legally marketed device, or different characteristics that do not raise different questions of safety and effectiveness. FDA
A De Novo request is the route for a novel low- to moderate-risk device with no equivalent on the market. When FDA grants it, the device is classified and can serve as the comparison device for later 510(k) submissions. FDA
Most low-risk Class I devices are exempt from premarket notification requirements. FDA
Each label names a different level of FDA review, from a full premarket approval to none at all. The table summarizes what FDA itself says about each. FDA

| Label | Applies to | What FDA reviewed before sale |
|---|---|---|
| FDA approved | Prescription and many OTC drugs, biologics, Class III devices | Safety and effectiveness, through an application |
| FDA cleared | Most Class II devices | Substantial equivalence to a device already on the market (510(k)) |
| De Novo granted | Novel low- to moderate-risk devices | Whether controls provide reasonable assurance of safety and effectiveness |
| OTC monograph drug | Nonprescription drugs such as many sunscreens and antacids | No individual application; must meet the monograph’s conditions |
| Compounded drug | Pharmacy-made drugs for an individual prescription | Not reviewed or approved |
| Dietary supplement | Vitamins, minerals, herbs and similar products | Not approved for safety or effectiveness |
| Cosmetic | Skin care and other cosmetic products | No approval required |
| “FDA registered” | A facility, or a drug or device listing | Registration does not denote approval |
No. FDA says compounded drugs are not FDA-approved, and that by statute compounders do not need to prove to FDA that their products meet the standards approved drugs meet. A compounded drug can still be lawful when a licensed pharmacy makes it for an individual prescription under federal rules. FDA
FDA gives examples of when compounding fits: a patient allergic to a dye who needs a version made without it, or a child or older adult who needs a liquid instead of a tablet. FDA
Ingredients a 503A pharmacy may use include those on FDA’s Category 1 interim list, such as NAD. Being on that list is not an approval. FDA
Some are and some are not individually approved. FDA describes two routes for a nonprescription drug: the drug application process, which leads to approval, and the OTC monograph process, under which a drug that meets a monograph’s conditions is generally recognized as safe and effective without its own application. FDA
An OTC drug monograph sets the conditions, such as active ingredients, uses, routes, labeling and testing, under which a nonprescription drug in a category like sunscreens or antacids is generally recognized as safe and effective. FDA
No. FDA does not approve dietary supplements for safety and effectiveness, and cosmetic products and ingredients do not require FDA approval, except color additives other than coal-tar hair dyes. Supplement companies must make sure their products are safe. FDA
The supplement label guide explains the “not evaluated by the Food and Drug Administration” disclaimer and what independent testing seals mean. FDA
Very little about quality. Drug and device makers register their facilities and list their products with FDA, but FDA says registration or listing does not denote approval of the establishment, the drug or the device. FDA
Outside every one of these categories. A peptide sold “for research use only” is not approved, cleared, lawfully compounded or a supplement. FDA treats such products as unapproved drugs when they are marketed for people, and has sent warning letters to sellers. FDA warning letter
Use FDA’s own databases rather than a seller’s claim, and look for the exact product name, not just the ingredient.
Adds Semaglutide, NAD+, Minoxidil, Melatonin to My Journal, with the questions to ask a clinician. It stays in this browser, and nothing on it is a commitment.
Licensed providers that list each one on DiscoverMedica, by name. The full list is on each compound’s page.
Prices as listed by the provider when we checked; they change.
No. “Cleared” applies to devices that went through a 510(k) review, showing substantial equivalence to a device already on the market. “Approved” applies to drugs, biologics and the highest-risk devices after a full premarket review.
No. Compounded drugs are not FDA-approved, though they can be lawful when a licensed pharmacy makes them for an individual prescription.
No. FDA does not approve dietary supplements for safety or effectiveness before they are sold. A supplement that claims FDA approval is misdescribing its status.
Some are. Semaglutide, tirzepatide, liraglutide and tesamorelin are FDA-approved peptide drugs. Many peptides sold online are research chemicals with no approval for human use.
Last reviewed October 7, 2026. Every source above was checked on or before that date. Educational information only, not medical advice; it does not replace a conversation with a licensed clinician. DiscoverMedica does not employ clinicians.
A GLP-1 medication that reduces appetite, approved for weight management and type 2 diabetes.
A coenzyme every cell uses for energy; offered as IV drips and injections at longevity clinics.
A hair-growth drug: topical over the counter, or a low-dose pill prescribed off-label.
The body's own sleep-timing hormone, sold as a supplement for jet lag and trouble falling asleep.
A lab-made peptide popular for injury recovery. Mostly animal data, and not an approved drug.